ICON News
Most Popular ICON Story
Icon buys Prevalere for $35M
Dublin-based Icon is forking over $35 million for New York's Prevalere, a provider of bioanalytical and immunoassay laboratory services. Prevalere could gain an additional $8.2 million if certain... Read more...
Latest Headlines
- November 20, 2008
- November 14, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
